Vitamin D levels in Chinese patients with systemic lupus erythematosus: relationship with disease activity, vascular risk factors and atherosclerosis

被引:88
|
作者
Mok, Chi Chiu [1 ]
Birmingham, Daniel J. [2 ]
Leung, Hoi Wah [1 ]
Hebert, Lee A. [2 ]
Song, Huijuan [2 ]
Rovin, Brad H. [2 ]
机构
[1] Tuen Mun Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China
[2] Ohio State Univ, Med Ctr, Dept Med, Columbus, OH 43210 USA
关键词
vitamin D; atherosclerosis; cholecalciferol; disease activity; traditional risk factors; NUTRITION EXAMINATION SURVEY; 25-HYDROXYVITAMIN D LEVELS; D DEFICIENCY; CARDIOVASCULAR RISK; 1,25-DIHYDROXYVITAMIN D-3; AUTOIMMUNE-DISEASES; NATIONAL-HEALTH; D-RECEPTOR; SLE; PREVALENCE;
D O I
10.1093/rheumatology/ker212
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. To study the relationship of 25(OH)D-3 level with disease activity, vascular risk factors and atherosclerosis in SLE. Methods. Consecutive patients who fulfilled four or more ACR criteria for SLE were recruited for assay of 25(OH)D-3 level. Disease activity was assessed by the SLEDAI and physicians' global assessment (PGA). Patients with vascular risk factors were screened for atherosclerosis at the coronary or carotid arteries. Correlation between 25(OH)D-3 levels and SLEDAI scores was studied by linear regression. The link between vascular risk factors, atherosclerosis and vitamin D deficiency was also examined. Results. A total of 290 SLE patients were studied [94% women; mean (s.d.) age 38.9 (13.1) years; disease duration 7.7 (6.7) years; 78% patients had clinical or serological lupus activity]. Two hundred and seventy-seven (96%) patients had vitamin D insufficiency [25(OH)D-3 < 30 ng/ml] and 77 (27%) patients had vitamin D deficiency (< 15 ng/ml). Levels of 25(OH)D-3 correlated inversely with PGA (beta -0.20; P = 0.003), total SLEDAI scores (beta -0.19; P = 0.003) and subscores due to active renal, musculoskeletal and haematological disease. Subjects with vitamin D deficiency had significantly higher total/high-density lipoprotein (HDL) cholesterol ratio [3.96 (2.94) vs 3.07 (0.80); P = 0.02] and prevalence of aPLs (57 vs 39%; P = 0.007). Of 132 patients, 58 (44%) with vascular risk factors screened were positive for subclinical atherosclerosis. No association could be demonstrated between 25(OH)D-3 level and atherosclerosis, which was mainly associated with increasing age, menopause, obesity and hyper-triglyceridaemia. Conclusions. In this large cross-sectional study of SLE patients, 25(OH)D-3 level correlates inversely with disease activity. Vitamin D deficiency is associated with dyslipidaemia. In patients with vascular risk factors, subclinical atherosclerosis is not associated with hypovitaminosis D.
引用
收藏
页码:644 / 652
页数:9
相关论文
共 50 条
  • [21] Vitamin D levels in Indian systemic lupus erythematosus patients: association with disease activity index and interferon alpha
    Mandal, Manamita
    Tripathy, Rina
    Panda, Aditya K.
    Pattanaik, Sarit S.
    Dakua, Simanchal
    Pradhan, Anjan Kumar
    Chakraborty, Soumen
    Ravindran, Balachandran
    Das, Bidyut K.
    ARTHRITIS RESEARCH & THERAPY, 2014, 16 (01)
  • [22] Vitamin D supplementation in systemic lupus erythematosus: relationship to disease activity, fatigue and the interferon signature gene expression
    Magro, Rosalie
    Saliba, Christian
    Camilleri, Liberato
    Scerri, Christian
    Borg, Andrew A.
    BMC RHEUMATOLOGY, 2021, 5 (01)
  • [23] Vitamin D levels and disease status in Texas patients with systemic lupus erythematosus
    Thudi, Amitha
    Yin, Su
    Wandstrat, Amy E.
    Li, Quan-Zhen
    Olsen, Nancy J.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2008, 335 (02) : 99 - 104
  • [24] Metabolic syndrome in systemic lupus erythematosus patients: Relationship to disease activity and neuropsychiatric lupus
    Hammam, N.
    Rashad, S. M.
    Mohamed, A. A. A.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2018, 77 (10): : 938 - 945
  • [25] Changes in Vitamin D Levels in Patients With Systemic Lupus Erythematosus: Effects on Fatigue, Disease Activity, and Damage
    Ruiz-Irastorza, Guillermo
    Gordo, Susana
    Olivares, Nerea
    Egurbide, Maria-Victoria
    Aguirre, Ciriaco
    ARTHRITIS CARE & RESEARCH, 2010, 62 (08) : 1160 - 1165
  • [26] The Effect of Vitamin D on Systemic Lupus Erythematosus' Disease Activity: An Evidence-Based Case Report
    Chandra, A. F.
    Subekti, I.
    ADVANCED SCIENCE LETTERS, 2017, 23 (07) : 7015 - 7018
  • [27] Vitamin D may not be a good marker of disease activity in Korean patients with systemic lupus erythematosus
    Hyoun-Ah Kim
    Jun-Mo Sung
    Ja-Young Jeon
    Jeong-Moon Yoon
    Chang-Hee Suh
    Rheumatology International, 2011, 31 : 1189 - 1194
  • [28] Relationship between vitamin D, IFN-γ, and E2 levels in systemic lupus erythematosus
    Kokic, V.
    Kaliterna, D. Martinovic
    Radic, M.
    Perkovic, D.
    Cvek, M.
    Capkun, V.
    LUPUS, 2016, 25 (03) : 282 - 288
  • [29] CONVENTIONAL RISK FACTORS, UNCONVENTIONAL AND LUPUS FOR ATHEROSCLEROSIS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Navarro, Maria
    Acevedo, Yubert
    Castillo, Angelo
    Lopez, Mariela
    Ruiz, Maria
    Bofelli, Catalina
    Rodriguez, Gisela
    Lizardo, Maria
    Vicci, Hember
    Camacho, Marqjuly
    COMUNIDAD Y SALUD, 2014, 12 (01) : 11 - 19
  • [30] Pentraxin 3 is associated with disease activity but not atherosclerosis in patients with systemic lupus erythematosus
    Shimada, Yuki
    Asanuma, Yu Funakubo
    Yokota, Kazuhiro
    Yoshida, Yoshihiro
    Kajiyama, Hiroshi
    Sato, Kojiro
    Akiyama, Yuji
    Mimura, Toshihide
    MODERN RHEUMATOLOGY, 2014, 24 (01) : 78 - 85